Interact to see
Advertisement
Advertisement
CURE vs SPXL
CURE vs SPXL Comparison Chart in %
Loading...
Show more...
Show more...
View a ticker or compare two or three
VS
VS
CURE vs. SPXL commentary
Sep 07, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CURE is a StrongBuy and SPXL is a StrongBuy.
SUMMARIES
FUNDAMENTALS
Fundamentals
SPXL has more net assets: 5.49B vs. CURE (167M). SPXL has a higher annual dividend yield than CURE: SPXL (15.915) vs CURE (-11.125). CURE was incepted earlier than SPXL: CURE (14 years) vs SPXL (17 years). SPXL (0.87) has a lower expense ratio than CURE (0.93). SPXL has a higher turnover CURE (23.00) vs CURE (23.00).
| CURE | SPXL | CURE / SPXL | |
| Gain YTD | -11.125 | 15.915 | -70% |
| Net Assets | 167M | 5.49B | 3% |
| Total Expense Ratio | 0.93 | 0.87 | 107% |
| Turnover | 23.00 | 29.00 | 79% |
| Yield | 1.36 | 0.82 | 166% |
| Fund Existence | 14 years | 17 years | - |
TECHNICAL ANALYSIS
Technical Analysis
| CURE | SPXL | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 83% |
| Stochastic ODDS (%) | 2 days ago 85% | 2 days ago 88% |
| Momentum ODDS (%) | 2 days ago 83% | 2 days ago 90% |
| MACD ODDS (%) | 2 days ago 90% | 2 days ago 84% |
| TrendWeek ODDS (%) | 2 days ago 90% | 2 days ago 87% |
| TrendMonth ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| Advances ODDS (%) | 2 days ago 90% | 3 days ago 90% |
| Declines ODDS (%) | 10 days ago 90% | 5 days ago 89% |
| BollingerBands ODDS (%) | N/A | N/A |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 90% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Show more...
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SBIO | 37.01 | 0.86 | +2.37% |
| ALPS Medical Breakthroughs ETF | |||
| RQI | 12.63 | 0.18 | +1.45% |
| COHEN & STEERS QUALITY Income REALTY FUND | |||
| IBGB | 24.92 | 0.33 | +1.33% |
| iShares iBonds Dec 2045 Term Trsy ETF | |||
| KROP | 31.84 | 0.14 | +0.45% |
| Global X AgTech & Food Innovation ETF | |||
| FAD | 155.72 | 0.12 | +0.08% |
| First Trust Multi Cap Gr AlphaDEX® ETF | |||
CURE and
Correlation & Price change
A.I.dvisor indicates that over the last year, CURE has been closely correlated with TMO. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if CURE jumps, then TMO could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To CURE | 1D Price Change % | ||
|---|---|---|---|---|
| CURE | 100% | +0.93% | ||
| TMO - CURE | 69% Closely correlated | +0.64% | ||
| MTD - CURE | 66% Loosely correlated | +1.39% | ||
| DHR - CURE | 65% Loosely correlated | +0.59% | ||
| A - CURE | 64% Loosely correlated | +0.21% | ||
| TECH - CURE | 64% Loosely correlated | +2.82% | ||
More | ||||